GB0905664D0 - Compounds for treatment of duchenne muscular dystrophy - Google Patents
Compounds for treatment of duchenne muscular dystrophyInfo
- Publication number
- GB0905664D0 GB0905664D0 GBGB0905664.9A GB0905664A GB0905664D0 GB 0905664 D0 GB0905664 D0 GB 0905664D0 GB 0905664 A GB0905664 A GB 0905664A GB 0905664 D0 GB0905664 D0 GB 0905664D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- treatment
- muscular dystrophy
- duchenne muscular
- duchenne
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0905664.9A GB0905664D0 (en) | 2009-04-02 | 2009-04-02 | Compounds for treatment of duchenne muscular dystrophy |
| PCT/EP2009/065132 WO2010112093A1 (en) | 2009-04-02 | 2009-11-13 | Benzoxazoles for the treatment of duchenne muscular dystrophy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0905664.9A GB0905664D0 (en) | 2009-04-02 | 2009-04-02 | Compounds for treatment of duchenne muscular dystrophy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0905664D0 true GB0905664D0 (en) | 2009-05-13 |
Family
ID=40672145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0905664.9A Ceased GB0905664D0 (en) | 2009-04-02 | 2009-04-02 | Compounds for treatment of duchenne muscular dystrophy |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB0905664D0 (en) |
| WO (1) | WO2010112093A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9246108B2 (en) | 2012-12-28 | 2016-01-26 | Dow Global Technologies Llc | Quinoline-benzoxazole derived compounds for electronic films and devices |
| GB201412010D0 (en) | 2014-07-04 | 2014-08-20 | Summit Corp Plc | Treatment of hypertransaminasemia |
| SG11201701600QA (en) * | 2014-08-29 | 2017-03-30 | Chdi Foundation Inc | Probes for imaging huntingtin protein |
| AU2015308709B2 (en) | 2014-08-29 | 2020-01-02 | Chdi Foundation, Inc. | Probes for imaging huntingtin protein |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9815880D0 (en) * | 1998-07-21 | 1998-09-16 | Pfizer Ltd | Heterocycles |
| JP5376956B2 (en) * | 2006-02-10 | 2013-12-25 | スムミト コーポレーション ピーエルシー | Treatment of Duchenne muscular dystrophy |
-
2009
- 2009-04-02 GB GBGB0905664.9A patent/GB0905664D0/en not_active Ceased
- 2009-11-13 WO PCT/EP2009/065132 patent/WO2010112093A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010112093A1 (en) | 2010-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0815369D0 (en) | Compounds for treatment of duchenne muscular dystrophy | |
| GB0821307D0 (en) | Compounds for treatment of duchenne muscular dystrophy | |
| GB0822981D0 (en) | Compounds for treatment of duchenne muscular dystrophy | |
| GB0715938D0 (en) | Method of treatment of duchenne muscular dystrophy | |
| IL228598A0 (en) | Treatment of duchenne muscular dystrophy | |
| LT2170396T (en) | Drug combinations for the treatment of duchenne muscular dystrophy | |
| GB0715087D0 (en) | Drug combinations for the treatment of duchenne muscular dystrophy | |
| IL193314A0 (en) | Treatment of duchenne muscular dystrophy | |
| ME02347B (en) | Rostafuroxine for pharmacogenomic treatment of cardiovascular conditions | |
| ZA200806986B (en) | Treatment of duchenne muscular dystrophy | |
| GB0715939D0 (en) | Method of treatment of duchenne muscular dystrophy | |
| EP2576582A4 (en) | Treatment of muscular dystrophy | |
| GB0905664D0 (en) | Compounds for treatment of duchenne muscular dystrophy | |
| GB0905670D0 (en) | Compounds for treatment of duchenne muscular dystrophy | |
| GB0809314D0 (en) | Compounds for treating muscular dystrophy | |
| GB0905667D0 (en) | Compounds for treatment of duchenne muscular dystrophy | |
| HK1178057A1 (en) | Treatment of osteoporosis | |
| GB0901417D0 (en) | Compounds for treatment of duchenne muscular dystrophy | |
| GB0902411D0 (en) | Compounds for treatment of duchenne muscular dystrophy | |
| GB0901794D0 (en) | Compounds for treating muscular dystrophy | |
| GB0803906D0 (en) | Compounds for treating duchenne muscular dystrophy | |
| GB0807216D0 (en) | Drug combination for the treatment of duchenne muscular dystrophy | |
| GB0913427D0 (en) | Compounds for treatment of imflammation | |
| EG26997A (en) | Tube for treatment of syrngomylia | |
| GB0617737D0 (en) | Treatment of duchenne muscular dystrophy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |